The US Food and Drug Administration (FDA) approves the first self-administered nasal spray flu vaccine.
The United States announced on Friday, September 20, 2024, the authorization of the first nasal spray flu vaccine, FluMist, produced by AstraZeneca, which patients will be able to self-administer without the help of health personnel. FDA has approved FluMist for…